Audicus Omni 2 vs MDHearing Volt

The Audicus Omni 2 is a premium behind-the-ear OTC hearing aid priced at $1,898 that earned an A grade in our lab testing, placing it in the top 6% of the 65 OTC hearing aids we've evaluated. This two-time Expert's Choice Award winner (2023 and 2024) delivers consistently strong performance across multiple listening scenarios. In our testing, the Omni 2 demonstrated particular strength in speech clarity during quiet environments, scoring 4.2/5—a strong result that sits 1.38 points above the category average. Music streaming quality also impressed at 3.6/5, exceeding the category average by 1.68 points. Speech understanding in noisy environments scored 2.3/5, which is above the category average of 1.48 but represents mixed performance in absolute terms—meaning challenging noise situations may still prove difficult. The device offers flexible power options with both rechargeable and disposable batteries, and supports streaming from both iPhone and Android devices with hands-free capability. Feedback handling is excellent at 4.5/5, essentially matching the category average, while own-voice comfort scores a solid 3.0/5. The Audicus Omni 2 is best suited for consumers seeking a premium OTC option with strong everyday speech clarity and quality streaming capabilities. Those frequently in very noisy environments should set realistic expectations, though the device still outperforms most OTC competitors in these conditions.

The MDHearing Volt is a budget-priced prescription hearing aid available for $397, earning a B grade with a SoundScore of 3.1/5 in our lab testing. This behind-the-ear, rechargeable device ranks #32 of 36 prescription hearing aids tested, placing it in the top 86% of its category. In our standardized testing, the Volt demonstrates excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. This represents a genuine strength, as the device remained stable under our challenge protocols without audible squealing or whistling. However, speech performance presents significant limitations: speech in quiet scored 1.8/5 (1.57 points below the category average of 3.32), while speech in noise scored 1.0/5 (0.96 points below the 1.96 average). Own-voice comfort measured 2.6/5, a mixed result that falls 0.15 points below the category average. Music streaming is notably limited at 0.0/5, scoring 2.64 points below the category average—users prioritizing phone streaming should consider alternatives. The Volt showed no improvement between Initial and Tuned fits, with both configurations yielding identical scores of 3.1/5. The MDHearing Volt may suit budget-conscious consumers who prioritize basic amplification and excellent feedback stability over speech clarity or streaming features. However, shoppers in this price range should note that alternatives like the RxEars Rxi offer substantially higher performance at similar pricing.